Immune Regulation of Viral Persistence and Clearance
病毒持续存在和清除的免疫调节
基本信息
- 批准号:8462531
- 负责人:
- 金额:$ 37.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:Antibody FormationAntiviral AgentsB-LymphocytesCD4 Positive T LymphocytesCell Differentiation processCell physiologyCellsCharacteristicsCompetenceDevelopmentEnvironmentEventExploratory/Developmental Grant for Diagnostic Cancer ImagingFailureGoalsHelper-Inducer T-LymphocyteImmuneImmunityImmunosuppressive AgentsInfectionInfection preventionInstitutesLymphocytic choriomeningitis virusMediatingMemoryMolecularPlayPrincipal InvestigatorProliferatingRegulationResidual stateRoleShapesSignal TransductionT-Cell DevelopmentT-LymphocyteTimeUp-RegulationViralVirusVirus DiseasesWorkexhaustexhaustiongenetic analysisimmunopathologymouse modelnovelpreventprogramsresponsetherapy designtherapy development
项目摘要
DESCRIPTION (provided by applicant): T cell immunity is crucial to control viral infection and prevent persistence. However, T cell functions are rapidly aborted during persistent infection, preventing viral clearance. Mounting evidence indicates that CD4 T cell helper responses are required to sustain immune competence and that the loss of CD4 T cell function is a key event permitting viral persistence. Many of the functional characteristics of CDS T cell exhaustion (failure to sustain activity, proliferate, develop memory) can potentially be explained by the loss of CD4 help. Despite immune exhaustion some persistent viral infections are eventually resolved via unknown CD4 T cell dependent mechanisms, suggesting that CD4 T cells retain helper function during viral persistence. Recently, we discovered that upregulation of IL-21 by CD4 T cells is absolutely required to sustain antiviral immunity and resolve an established persistent viral infection. The goal of this application is to understand how CD4 T cell help is altered during viral persistence and ultimately to identify the IL-21 mediated mechanisms that sustain immunity. To achieve this goal we will use the mouse model of lymphocytic choriomeningitis virus (LCMV) infection to explore virus-specific CD4 T helper differentiation during viral persistence and how IL-21 directs this developmental program. Next, we will define the mechanism whereby IL-21 simultaneously suppresses CD4 T cell mediated immunopathology and sustains CDS T cell immunity to resolve persistent viral infection. These studies will investigate a novel mechanism of CD4 T cell help during viral persistence (at a time when CD4 T cell function was previously considered lost) and will be the first to identify the immune components that resolve an established persistent viral infection. It is important to identify the mechanisms that alternatively sustain and suppress antiviral immunity to develop therapies to restore T cell function and potentially cure persistent infection.
描述(由申请人提供):T 细胞免疫对于控制病毒感染和防止病毒持续存在至关重要。然而,在持续感染期间,T 细胞功能会迅速中止,从而阻止病毒清除。越来越多的证据表明,维持免疫能力需要 CD4 T 细胞辅助反应,而 CD4 T 细胞功能的丧失是病毒持续存在的关键事件。 CDS T 细胞耗竭的许多功能特征(无法维持活性、增殖、形成记忆)可能可以用 CD4 帮助的丧失来解释。尽管免疫衰竭,但一些持续性病毒感染最终通过未知的 CD4 T 细胞依赖性机制得到解决,这表明 CD4 T 细胞在病毒持续存在期间保留了辅助功能。最近,我们发现 CD4 T 细胞对 IL-21 的上调对于维持抗病毒免疫和解决已确定的持续性病毒感染是绝对必需的。该应用的目标是了解 CD4 T 细胞在病毒持续存在期间如何改变,并最终确定维持免疫的 IL-21 介导机制。为了实现这一目标,我们将使用淋巴细胞性脉络膜脑膜炎病毒 (LCMV) 感染的小鼠模型来探索病毒持续存在期间病毒特异性 CD4 T 辅助细胞分化以及 IL-21 如何指导这一发育程序。接下来,我们将定义 IL-21 同时抑制 CD4 T 细胞介导的免疫病理学并维持 CDS T 细胞免疫以解决持续性病毒感染的机制。这些研究将调查 CD4 T 细胞在病毒持续存在期间(当时 CD4 T 细胞功能被认为丧失)的新机制,并将首次鉴定出解决已建立的持续病毒感染的免疫成分。重要的是要确定维持和抑制抗病毒免疫的机制,以开发恢复 T 细胞功能并有可能治愈持续性感染的疗法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells.
病毒持久性将 CD4 T 细胞分化为滤泡辅助 T 细胞。
- DOI:
- 发表时间:2011-05-09
- 期刊:
- 影响因子:0
- 作者:Fahey LM;Wilson EB;Elsaesser H;Fistonich CD;McGavern DB;Brooks DG
- 通讯作者:Brooks DG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID G BROOKS其他文献
DAVID G BROOKS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID G BROOKS', 18)}}的其他基金
Immune Regulation of Viral Persistence and Clearance
病毒持续存在和清除的免疫调节
- 批准号:
8261329 - 财政年份:2009
- 资助金额:
$ 37.91万 - 项目类别:
相似国自然基金
基于激发植物免疫为导向的嘧啶酮类高效抗病毒剂设计合成及作用机制研究
- 批准号:21807037
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
云南地方晾晒烟中的内源性抗烟草花叶病毒活性成分研究
- 批准号:31860100
- 批准年份:2018
- 资助金额:41.0 万元
- 项目类别:地区科学基金项目
两种植物中抗烟草花叶病毒先导化合物的结构优化、构效关系及作用机制研究
- 批准号:31760089
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
基于kealiinine类海洋生物碱的新型抗病毒剂的设计合成、构效关系及作用机制研究
- 批准号:21772145
- 批准年份:2017
- 资助金额:64.0 万元
- 项目类别:面上项目
生态农药的分子设计与作用机制
- 批准号:21732002
- 批准年份:2017
- 资助金额:300.0 万元
- 项目类别:重点项目
相似海外基金
Innate Control of Adaptive Immunity to SARS-CoV-2
对 SARS-CoV-2 的适应性免疫的先天控制
- 批准号:
10284699 - 财政年份:2021
- 资助金额:
$ 37.91万 - 项目类别:
Harnessing targeted IL-2 to reduce immunopathology and enhance immunity against respiratory virus infection
利用靶向 IL-2 来减少免疫病理并增强对呼吸道病毒感染的免疫力
- 批准号:
10334690 - 财政年份:2021
- 资助金额:
$ 37.91万 - 项目类别:
Protective and Pathogenic T Cells Responding to SARS-CoV-2 in Health and Disease
健康和疾病中对 SARS-CoV-2 做出反应的保护性和致病性 T 细胞
- 批准号:
10218954 - 财政年份:2021
- 资助金额:
$ 37.91万 - 项目类别:
The cellular mechanisms of immunological memory development in COVID-19 patients
COVID-19患者免疫记忆发展的细胞机制
- 批准号:
10465343 - 财政年份:2021
- 资助金额:
$ 37.91万 - 项目类别:
Autologous HIV antibodies for viral control
用于病毒控制的自体 HIV 抗体
- 批准号:
10327100 - 财政年份:2021
- 资助金额:
$ 37.91万 - 项目类别: